Difference between revisions of "Work Product for Review"

From QIBA Wiki
Jump to navigation Jump to search
 
(14 intermediate revisions by 4 users not shown)
Line 1: Line 1:
==Public Comment on QIBA Profiles and Protocols==
+
[[Image:QIBA_WIKI_BLURB.jpg|600px]]
QIBA documents are posted for Public Comment to ensure stakeholder representation, transparency and quality review. Interested people are encouraged to provide input on the document, the scenarios and use cases they address, the technologies proposed and other details. 
 
  
The [[Committees|QIBA Biomarker Committees]] consider all comments submitted, and where appropriate, post responses.
+
<font color="red">NOTICE: These instructions are accessible on the QIBA Wiki as a historical reference only! Independent Profile Authoring Groups are required to oversee the various developmental stages from Draft to Public Comment to Consensus based on the current QUIC endorsement criteria, found HERE:</font> https://qibawiki.rsna.org/images/9/95/QUIC-Review-Criteria-for-New-Profiles-FINAL-v23SEPT2023.pdf.
  
==Comment Submission==
 
  
* Visit the [https://fs22.formsite.com/QIBA/QIBA_Public_Comment_Form/index.html QIBA Public Comment Webform].
+
QIBA '''[[Profiles|Profile documents]]''' are posted for '''[[Public Comment Process|Public Comment]]''' to ensure stakeholder representation, transparency and quality review. Interested people are encouraged to provide input on the document, the scenarios and use cases they address, the technologies proposed and other details.
:* Select the document you are commenting on from the dropdown menu
 
:* Provide your name or initials
 
:* Follow the other instructions on the page
 
* e-mail ([mailto:sweinmann@rsna.org Susan Weinmann]) with ''general comments'' about the Profile/Protocol concept, structure, process, etc.
 
  
 +
==Comment Submission==
  
==QIBA Profiles and Protocols for Reference==
+
* ** provide a link to a public comment form (Google forms are recommended for ease of data capture) - ''see example'': [[Image:public comment form.jpg |1200px]]
 
+
:* Select the document you are commenting on from the appropriate form
*[[Media:001.QIBA SPECT Profile.v0.1 2016.10.28.docx | QIBA Profile: <big><font color=red> QIBA Profile: Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016</font></big>]] ''The Public Comment period ends February 1, 2017.''
+
:* Provide your name and email address
 
+
:* Add the Profile section and line number (if applicable) to which your comment refers
*[[Media:002.QIBA SPECT Profile Checklist Extract.2016 10 31.docx|QIBA SPECT Profile Conformance Checklist]]
+
:* Describe the issue and your propose a resolution
 
+
:* When you have entered each of your comments, you may submit the form
 +
* e-mail Profile Authoring Group with ''general comments'' about the Profile/Protocol concept, structure, process, etc.
  
*[[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_v5-2-16b.docx|QIBA Profile: <big><font color=red> QIBA Profile: Lung Nodule Volume Assessment and Monitoring in Low Dose CT Screening, June 1, 2016</font></big>]] ''The Public Comment period has closed''
+
The [[Committees|QIBA Biomarker Committees]] consider all comments submitted, and where appropriate, post responses.
  
*[[Media:QIBA Small Nodule Profile References - Accuracy.xlsx|QIBA Spreadsheet: <big><font color=red> Small Nodule Profile References_Accuracy. Version for Public Comment. June 1, 2016 </font></big>]] ''The Public Comment period has closed''
+
==Public Comment Documents==
  
*[[Media:QIBA Small Nodule Profile References - Precision.xlsx|QIBA Spreadsheet: <big><font color=red> Small Nodule Profile References_Precision. Version for Public Comment. June 1, 2016 </font></big>]] ''The Public Comment period has closed''
+
see http://qibawiki.rsna.org/index.php/Profiles
  
  
 
*[[Document Archive]]
 
*[[Document Archive]]

Latest revision as of 16:56, 19 January 2024

QIBA WIKI BLURB.jpg

NOTICE: These instructions are accessible on the QIBA Wiki as a historical reference only! Independent Profile Authoring Groups are required to oversee the various developmental stages from Draft to Public Comment to Consensus based on the current QUIC endorsement criteria, found HERE: https://qibawiki.rsna.org/images/9/95/QUIC-Review-Criteria-for-New-Profiles-FINAL-v23SEPT2023.pdf.


QIBA Profile documents are posted for Public Comment to ensure stakeholder representation, transparency and quality review. Interested people are encouraged to provide input on the document, the scenarios and use cases they address, the technologies proposed and other details.

Comment Submission

  • ** provide a link to a public comment form (Google forms are recommended for ease of data capture) - see example: Public comment form.jpg
  • Select the document you are commenting on from the appropriate form
  • Provide your name and email address
  • Add the Profile section and line number (if applicable) to which your comment refers
  • Describe the issue and your propose a resolution
  • When you have entered each of your comments, you may submit the form
  • e-mail Profile Authoring Group with general comments about the Profile/Protocol concept, structure, process, etc.

The QIBA Biomarker Committees consider all comments submitted, and where appropriate, post responses.

Public Comment Documents

see http://qibawiki.rsna.org/index.php/Profiles